Santen Pharmaceutical Co., Ltd.
SNPHY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $63,560,000 | $84,578,000 | $92,997,000 | $77,851,000 |
| Short-Term Investments | $2,524,000 | $0 | $997,000 | $0 |
| Receivables | $62,691,000 | $67,398,000 | $71,759,000 | $69,066,000 |
| Inventory | $59,282,000 | $59,247,000 | $51,590,000 | $49,998,000 |
| Other Curr. Assets | $7,091,000 | $10,195,000 | $6,957,000 | $8,223,000 |
| Total Curr. Assets | $195,148,000 | $221,418,000 | $224,300,000 | $205,138,000 |
| Property Plant & Equip (Net) | $74,812,000 | $72,715,000 | $72,954,000 | $74,387,000 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $77,583,000 | $73,677,000 | $75,467,000 | $79,612,000 |
| Long-Term Investments | $0 | $0 | $26,539,000 | $28,940,000 |
| Tax Assets | $10,614,000 | $0 | $10,017,000 | $0 |
| Other NC Assets | $30,979,000 | $40,313,000 | $1,000 | $10,230,000 |
| Total NC Assets | $193,988,000 | $186,705,000 | $184,978,000 | $193,169,000 |
| Other Assets | $1,000 | $0 | -$1,000 | $0 |
| Total Assets | $389,137,000 | $408,123,000 | $409,277,000 | $398,307,000 |
| Liabilities | – | – | – | – |
| Payables | $30,612,000 | $42,361,000 | $38,989,000 | $35,791,000 |
| Short-Term Debt | $0 | $0 | $274,000 | $0 |
| Tax Payable | $3,092,000 | $0 | $2,239,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $39,873,000 | $44,070,000 | $42,320,000 | $42,738,000 |
| Total Curr. Liab. | $73,577,000 | $86,431,000 | $86,837,000 | $78,529,000 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2,709,000 | $0 | $2,606,000 | $0 |
| Other NC Liab. | $39,244,000 | $41,478,000 | $34,653,000 | $36,567,000 |
| Total NC Liab. | $41,953,000 | $41,478,000 | $37,259,000 | $36,567,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $7,472,000 | $0 |
| Total Liabilities | $115,530,000 | $127,909,000 | $124,096,000 | $115,096,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8,816,000 | $8,808,000 | $8,806,000 | $8,797,000 |
| Retained Earnings | $235,744,000 | $227,682,000 | $228,291,000 | $227,374,000 |
| AOCI | $330,000 | $43,944,000 | $40,509,000 | $47,841,000 |
| Other Equity | $48,736,000 | $0 | $0 | $0 |
| Total Equity | $274,767,000 | $281,265,000 | $286,242,000 | $284,028,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1,160,000 | -$1,051,000 | -$1,061,000 | -$817,000 |
| Total Liab. & Tot. Equity | $389,137,000 | $408,123,000 | $409,277,000 | $398,307,000 |
| Net Debt | -$63,560,000 | -$84,578,000 | -$92,723,000 | -$77,851,000 |